PTX3 and Sepsis: It has been demonstrated in previous work that early identification and protocol-based treatment of severe sepsis can improve the survival of patients. In recent years, there are many novel biomarkers, including PTX3, C-reactive protein (CRP), PCT, and plasma PTX3, that are identified to early anticipate sepsis and plan treatment [14].